Vor Biopharma Inc. (VOR) Misses Q3 EPS by 12150c

Vor Biopharma Inc. (NASDAQ: VOR) reported Q3 EPS of ($121.60), $121.50 worse than the analyst estimate of ($0.10).

For earnings history and earnings-related data on Vor Biopharma Inc. (VOR) click here.

You May Also Be Interested In

• Movano (MOVE) Misses Q2 EPS by 195c
• AI/ML Innovations plans $2M private placement on the CSE
• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August